# Dyne Therapeutics, Inc.: Form 8-K, filed Mar 5, 2024

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2024-03-05
- Accepted by EDGAR: Mar 5, 2024, 12:41 ET
- Period: 2024-03-05
- Accession: 0000950170-24-025408
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017024025408/dyn-20240305.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017024025408/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017024025408/dyn-20240305.htm

Filed Mar 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-025408. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.